[Blood group serologic monitoring in pregnancy and neonatal serology in the Tyrol].
The purpose of this study is to give an overall picture of the results obtained from antibody screening in 80,509 pregnancies, the influence of irregular antibodies on the outcome of the fetus and neonate and the frequency of exchange transfusions performed in babies suffering from hemolytic disease. With regard to the strength of agglutination in 1282 positive direct anti(human)globulin tests in newborns observations are made whether or not it would be possible to draw conclusions on the causative maternal antibody. Based upon the observed number of pregnancies at risk resulting in hemolytic disease of the fetus or neonate calculations are given concerning the estimated number of affected babies not identified in the Tyrolean population mainly due to insufficient technical methods or due to complete omission of serologic testing during pregnancy. Conclusions drawn from the results obtained from the serologic monitoring during pregnancy and at the time of delivery lead to suggestions for the improvement of the existing legal regulations, the observance of which enables the mother to receive an increased maternity grant.
D000328:Adult; D001317:Austria; D003298:Coombs Test; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005323:Fetal Monitoring; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D012203:Rh Isoimmunization / Q000517:prevention & control*
Die blutgruppenserologische Schwangerschaftsüberwachung und Neugeborenenserologie in Tirol.